These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Embryonal paratesticular rhabdomyosarcoma: a case report and a literature review].
    Author: Ghorbal L, Abid W, Elloumi F, Sallemi T, Frikha M, Daoud J.
    Journal: Cancer Radiother; 2015 Aug; 19(5):334-6. PubMed ID: 26215365.
    Abstract:
    Paratesticular rhabdomyosarcoma is a rare tumor. Multimodality treatment should involve surgery, radiotherapy and chemotherapy, which are indicated according to risk groups. Risk group stratification depends on pretreatment staging and definitive histology. Patients older than 10years or those with suspected lymph nodes on imaging have higher incidence of lymph node involvement. Prognosis is excellent for localized tumors, survival rates exceed 90%. We report a case of embryonal paratesticular rhabdomyosarcoma treated in our institution.
    [Abstract] [Full Text] [Related] [New Search]